TABLE 2 .
Microbiologic identification and oxacillin susceptibility results for all subjects
| Identification or susceptibility result | No. (%) for SCV status: |
|
|---|---|---|
| Yes (n = 38) | No (n = 75) | |
| Species identification | ||
| S. aureus | 10 (26.3) | 25 (33.3) |
| S. epidermidis | 22 (57.9) | 40 (53.3) |
| S. capitis/caprae | 2 (5.3) | 3 (4) |
| S. lugdunensis | 3 (7.9) | 2 (2.7) |
| Staphylococcus warneri | 0 | 1 (1.3) |
| Multiple Staphylococcus speciesa | 1 (2.6) | 4 (5.3) |
| Oxacillin susceptibility result determined in clinical microbiology laboratory | ||
| Susceptible | 16 (42.1) | 28 (37.3) |
| Resistant | 17 (44.7) | 40 (53.3) |
| Both susceptible and resistant isolated in clinical laboratory | 5 (13.2) | 7 (9.3) |
a
The multiple organisms identified included S. epidermidis and S. warneri (n = 2), S. aureus and S. epidermidis (n = 1), S. aureus and S. capitis/caprae (n = 1), and Staphylococcus simulans and S. capitis/caprae (n = 1).